Concepts of CNS plasticity in the context of brain damage and repair

被引:57
作者
Stein, DG
Hoffman, SW
机构
[1] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
关键词
diaschisis; equipotentiality; neuroplasticity; neuroreorganization; neurotherapies; recovery of function; vicariation;
D O I
10.1097/00001199-200307000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: How effectively the brain can respond to injury and undergo structural repair has become one of the most exciting areas of contemporary basic and translational neuroscience research. Although there are no clinical treatments yet available to enhance repair of the damaged brain, there are a number of potential therapies being investigated. New drugs are designed to provide some degree of neuroprotection by preventing injured or vulnerable nerve cells from dying, or they are given in the hope of stimulating regenerative processes that could lead to the restoration or the formation of new connections that were lost because of the injury. Main outcome measures: The developments in pharmacology are based primarily upon understanding the molecular mechanisms of drug actions at the level of the genome or with respect to cellular metabolism. Although there is a substantial interest in the pharmacology of brain repair, there seems to be less concern with the various theories of central nervous system plasticity, organization, and reorganization after an injury. Conclusions: This review discusses some of the older and current ideas and theories that have been presented over the years to explain recovery of function. We then provide an overview of what is being done in the laboratory to develop new and safe drugs for the treatment of traumatic brain injuries.
引用
收藏
页码:317 / 341
页数:25
相关论文
共 163 条
[61]  
HEFTI F, 1994, NEUROBIOL AGING, V15, pS193
[62]   The NF-κB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia [J].
Hill, WD ;
Hess, DC ;
Carroll, JE ;
Wakade, CG ;
Howard, EF ;
Chen, Q ;
Cheng, C ;
Martin-Studdard, A ;
Waller, JL ;
Beswick, RA .
BRAIN RESEARCH BULLETIN, 2001, 55 (03) :375-386
[63]  
Hoffman SW, 1996, J NEUROSCI METH, V68, P133
[64]   Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles [J].
Hoffman, SW ;
Moore, S ;
Ellis, EF .
STROKE, 1997, 28 (04) :844-849
[65]  
HOFFMAN SW, IN PRESS J NEUROTRAU
[66]   Nogo-A, a potent inhibitor of neurite outgrowth and regeneration [J].
Huber, AB ;
Schwab, ME .
BIOLOGICAL CHEMISTRY, 2000, 381 (5-6) :407-419
[67]   EFFECT OF AGE AND GENDER ON TIRILAZAD PHARMACOKINETICS IN HUMANS [J].
HULST, LK ;
FLEISHAKER, JC ;
PETERS, GR ;
HARRY, JD ;
WRIGHT, DM ;
WARD, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) :378-384
[68]   Use-dependent exaggeration of brain injury: Is glutamate involved? [J].
Humm, JL ;
Kozlowski, DA ;
Bland, ST ;
James, DC ;
Schallert, T .
EXPERIMENTAL NEUROLOGY, 1999, 157 (02) :349-358
[69]   Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period [J].
Humm, JL ;
Kozlowski, DA ;
James, DC ;
Gotts, JE ;
Schallert, T .
BRAIN RESEARCH, 1998, 783 (02) :286-292
[70]  
Imahori Y, 1999, NEUROREPORT, V10, P117